Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04857151 · ClinicalTrials.gov registry record · Early Phase 1
Stress, Inflammation and Immune Response Pilot Study- Aim 3
A Early Phase 1 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
NCT04857151 is a Early Phase 1 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 3 participants.
The verdict
NCT04857151, a Early Phase 1 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The overall goal of this study is to investigate the effects of stress and glucose intake at the molecular level including gene expression, protein and functional analysis of immune cells in real time. Aim 1- Characterizing the immune response after acute stress and glucose consumption Aim 2- Temporal mapping of the modulation of immune cell function via meditation Aim 3-Influence of meditative practice on lupus patients Aim 4-Influence of meditative practice on healthy subjects Current Clinicaltrials.gov record, will be focused on Aim-3 only. Aim-3 will test whether meditation alters neutrophil function and inflammation in patients with lupus. Study team will investigate whether patient neutrophils have altered NET formation, phagocytosis, ROS signaling and migration after ABMP. Innate immune function via analysis of monocytes by flow cytometry will also be analyzed. Other immune cell responses including CD8 T cells will also be investigated.
Interventions
- BEHAVIORAL App based mindfulness program (ABMP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2022-02-02 |
| Est. Completion | 2024-03-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04857151
The ClinicalTrials.gov registry entry for NCT04857151 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which App based mindfulness program (ABMP) is the first listed.
NCT04857151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04857151 about?
NCT04857151 is a clinical study titled "Stress, Inflammation and Immune Response Pilot Study- Aim 3". The overall goal of this study is to investigate the effects of stress and glucose intake at the molecular level including gene expression, protein and functional analysis of immune cells in real time. Aim 1- Characterizing the immune response after acute stress and glucose consumption Aim 2- Tempo...
What is the current status of trial NCT04857151?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2022-02-02. Estimated completion is 2024-03-31.
What interventions are being tested in trial NCT04857151?
The interventions under investigation include: App based mindfulness program (ABMP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04857151?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.